TGTX
#991
TG Therapeutics, Inc. - Common Stock
57.9 7 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.88%
Changement Mensuel
+25.58%
Evolution sur 6 mois
+99.69%
Changement Annuel
+83.68%
Clôture Précédente
56.9 0
Open
58.4 7
Low
57.9 6
High
58.4 7
Volume
293
Financials
- Market Capitalization 8.87 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
20.05
ratio cours/chiffre d'affaires
10.98
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 978 |  ABVX Abivax SA - American Depositary Shares | 114.81 USD | +3.36% | -0.91% | -8.16% | +37.93% | 9.02 B USD | ||
| 979 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.95 USD | 0.00% | +0.09% | +1.40% | +106.69% | 9.01 B USD | ||
| 1016 |  IBRX ImmunityBio, Inc. - Common Stock | 7.96 USD | +0.13% | -7.66% | +17.23% | +234.45% | 8.44 B USD | ||
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | -0.01% | +0.07% | +0.61% | +152.04% | 8.40 B USD |